A reader's guide to the bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline.
作者信息
Grosset Jacques, Vernon Andrew
机构信息
1 Center for Tuberculosis Research Johns Hopkins University School of Medicine Baltimore, Maryland.
出版信息
Am J Respir Crit Care Med. 2015 Apr 15;191(8):871-3. doi: 10.1164/rccm.201502-0367ED.
Abstract
摘要
相似文献
1
A reader's guide to the bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline.吡嗪酰胺和氯法齐明单独及与普瑞玛尼和贝达喹啉联合使用时杀菌活性的读者指南
Am J Respir Crit Care Med. 2015 Apr 15;191(8):871-3. doi: 10.1164/rccm.201502-0367ED.
2
Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline.吡嗪酰胺和氯法齐明单独及与贝达喹啉和德拉马尼联合的杀菌活性。
Am J Respir Crit Care Med. 2015 Apr 15;191(8):943-53. doi: 10.1164/rccm.201410-1801OC.
3
Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis.贝达喹啉联合利奈唑胺或莫西沙星与吡嗪酰胺对鼠结核模型的新型方案的贡献。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.00021-19. Print 2019 May.
4
Contribution of the nitroimidazoles PA-824 and TBA-354 to the activity of novel regimens in murine models of tuberculosis.硝基咪唑类药物PA - 824和TBA - 354对新型抗结核治疗方案在小鼠结核病模型中活性的贡献。
Antimicrob Agents Chemother. 2015 Jan;59(1):129-35. doi: 10.1128/AAC.03822-14. Epub 2014 Oct 20.
5
A bedaquiline, pretomanid, moxifloxacin, and pyrazinamide regimen for drug-susceptible and drug-resistant tuberculosis.用于药物敏感和耐药结核病的贝达喹啉、普瑞玛胺、莫西沙星和吡嗪酰胺治疗方案。
Lancet Infect Dis. 2024 Sep;24(9):940-941. doi: 10.1016/S1473-3099(24)00257-3. Epub 2024 May 17.
6
Pharmacodynamics and Bactericidal Activity of Combination Regimens in Pulmonary Tuberculosis: Application to Bedaquiline-Pretomanid-Pyrazinamide.肺结核联合用药方案的药效学和杀菌活性：贝达喹啉-普托马尼-吡嗪酰胺的应用
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0089822. doi: 10.1128/aac.00898-22. Epub 2022 Nov 15.
7
A Bedaquiline, Pyrazinamide, Levofloxacin, Linezolid, and Clofazimine Second-line Regimen for Tuberculosis Displays Similar Early Bactericidal Activity as the Standard Rifampin-Based First-line Regimen.贝达喹啉、吡嗪酰胺、左氧氟沙星、利奈唑胺和氯法齐明二线方案治疗结核病的早期杀菌活性与标准利福平为基础的一线方案相似。
J Infect Dis. 2024 Aug 16;230(2):e447-e456. doi: 10.1093/infdis/jiad564.
8
Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis.维拉帕米增加贝达喹啉但不增加氯法齐明在结核分枝杆菌感染小鼠模型中的生物利用度和疗效。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01692-17. Print 2018 Jan.
9
Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolid.评估氯法齐明单独或与贝达喹啉、德拉马尼或利奈唑胺联合使用对结核分枝杆菌的效果。
Int J Antimicrob Agents. 2022 Feb;59(2):106509. doi: 10.1016/j.ijantimicag.2021.106509. Epub 2021 Dec 25.
10
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.贝达喹啉-pretomanid-莫西沙星-吡嗪酰胺治疗敏感和耐药肺结核：一项 2c 期、开放标签、多中心、部分随机对照试验。
Lancet Infect Dis. 2024 Sep;24(9):1003-1014. doi: 10.1016/S1473-3099(24)00223-8. Epub 2024 May 17.
引用本文的文献
1
Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169).优化背景治疗方案治疗活动期结核病与下一代苯并噻嗪酮 Macozinone (PBTZ169)。
Antimicrob Agents Chemother. 2018 Oct 24;62(11). doi: 10.1128/AAC.00840-18. Print 2018 Nov.
2
Update in Tuberculosis/Pulmonary Infections 2015.2015年结核病/肺部感染进展
Am J Respir Crit Care Med. 2016 Jul 15;194(2):142-6. doi: 10.1164/rccm.201601-0129UP.
3
Update in Mycobacterium tuberculosis lung disease 2014.2014年肺结核病的最新进展
Am J Respir Crit Care Med. 2015 Oct 1;192(7):793-8. doi: 10.1164/rccm.201505-1009UP.
本文引用的文献
1
Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline.吡嗪酰胺和氯法齐明单独及与贝达喹啉和德拉马尼联合的杀菌活性。
Am J Respir Crit Care Med. 2015 Apr 15;191(8):943-53. doi: 10.1164/rccm.201410-1801OC.
2
Clofazimine for the treatment of multidrug-resistant tuberculosis: prospective, multicenter, randomized controlled study in China.氯法齐明治疗耐多药结核病的前瞻性、多中心、随机对照研究在中国进行。
Clin Infect Dis. 2015 May 1;60(9):1361-7. doi: 10.1093/cid/civ027. Epub 2015 Jan 20.
3
Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis.氯法齐明可缩短结核病实验性化疗一线治疗方案的疗程。
Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):869-74. doi: 10.1073/pnas.1416951112. Epub 2015 Jan 5.
4
Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients.针对500多名连续患者的耐多药结核病的成功“孟加拉国9个月治疗方案” 。
Int J Tuberc Lung Dis. 2014 Oct;18(10):1180-7. doi: 10.5588/ijtld.14.0100.
5
Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary tuberculosis.随机剂量范围研究贝达喹啉（TMC207）在痰显微镜检查涂片阳性肺结核患者中的 14 天早期杀菌活性。
Antimicrob Agents Chemother. 2013 May;57(5):2199-203. doi: 10.1128/AAC.02243-12. Epub 2013 Mar 4.
6
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.PA-824、贝达喹啉、吡嗪酰胺和莫西沙星联合治疗的 14 天杀菌活性：一项随机试验。
Lancet. 2012 Sep 15;380(9846):986-93. doi: 10.1016/S0140-6736(12)61080-0. Epub 2012 Jul 23.
7
Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals.利用抗生素产生的羟基自由基根除细菌持久期细胞。
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12147-52. doi: 10.1073/pnas.1203735109. Epub 2012 Jul 9.
8
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.随机先导试验：使用贝达喹啉（TMC207）治疗 8 周治疗耐多药结核病：长期结果、耐受性和对耐药性出现的影响。
Antimicrob Agents Chemother. 2012 Jun;56(6):3271-6. doi: 10.1128/AAC.06126-11. Epub 2012 Mar 5.
9
Sterilizing activity of second-line regimens containing TMC207 in a murine model of tuberculosis.二线方案中包含 TMC207 对结核分枝杆菌感染小鼠模型的杀菌活性。
PLoS One. 2011 Mar 3;6(3):e17556. doi: 10.1371/journal.pone.0017556.
10
Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species.分枝杆菌型 2NADH：醌氧化还原酶还原氯法嗪：生成杀菌水平活性氧的途径。
J Biol Chem. 2011 Mar 25;286(12):10276-87. doi: 10.1074/jbc.M110.200501. Epub 2010 Dec 30.
Zotero 插件